Results 21 to 30 of about 7,309,579 (256)
Non-HDL cholesterol predicts coronary heart disease in primary prevention: findings from an Italian a 40-69 year-old cohort in general practice
Monaldi Archives for Chest Disease, 2004 Scopo. La frazione lipoproteica denominata “colesterolo non-HDL” viene raccomandata come un indice di rischio coronarico (RC) associata alla dislipidemia combinata ed è stata trovata un utile fattore predittivo del rischio coronarico nei pazienti ...Anna V. Ciardullo, Luigi Azzolini, Massimo Bevini, Tiziano Cadioli, Paolo Malavasi, Alberto Morellini, Monica M. Daghio, Patrizia Guidetti, Manuela Lorenzetti, Carlo Carapezzi +9 moredoaj +1 more sourceGender-Related Differences in the Prevalence of Cardiovascular Disease Risk Factors and their Correlates in Urban Tanzania. [PDF]
, 2009 \ud
Urban areas in Africa suffer a serious problem with dual burden of infectious diseases and emerging chronic diseases such as cardiovascular diseases (CVD) and diabetes which pose a serious threat to population health and health care resources ...Mpembeni, Rose, Muhihi Alfa, Finkelstein, Julia, Spiegelman Donna, Mpembeni, R., Hertzmark, E., Spiegelman, D., Hertzmark Ellen, Muhihi, A., Njelekela, Marina A, Mligiliche Nuru L, Mligiliche, N.L., Willett Walter C, Fawzi, Wafaie, Spiegelman, Donna, Liu, Enju, Willett, W.C., Mligiliche, Nuru L, Njelekela, M.A., Willett, Walter C, Fawzi, W.W., Hertzmark, Ellen, Mpembeni Rose, Finkelstein, Julia L, Liu Enju, Fawzi Wafaie W, Mtabaji, Jacob, Njelekela Marina A, Mtabaji Jacob, Finkelstein, J.L., Willett, Walter, Fawzi, Wafaie W, Finkelstein Julia L, Mtabaji, J., Liu, E., Muhihi, Alfa +35 morecore +1 more sourceSex X Time Interactions in Lp(a) and LDL-C Response to Evolocumab
Biomedicines, 2023 The aim of this study was to evaluate whether there were significant sex x time interactions in lipoprotein(a) (Lp(a)) and low-density lipoprotein cholesterol (LDL-C) response to treatment with the Proprotein Convertase Subtilisin/Kexin type 9 inhibitor (Federica Fogacci, Serra İlayda Yerlitaş, Marina Giovannini, Gökmen Zararsız, Paolo Lido, Claudio Borghi, Arrigo F. G. Cicero +6 moredoaj +1 more sourceUse of a community advisory board to build equitable algorithms for participation in clinical trials: a protocol paper for HoPeNET
BMJ Health & Care Informatics, 2022 Introduction Participation from racial and ethnic minorities in clinical trials has been burdened by issues surrounding mistrust and access to healthcare.Nicole Farmer, Valerie M Mitchell, Gwenyth R Wallen, Tiffany M Powell-Wiley, Allan Johnson, Foster Osei Baah, Faustine Williams, Erika Ortiz-Chapparo, Latifa Jackson, Billy Collins, Lennox Graham +10 moredoaj +1 more sourceLipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study
Biomedicines, 2022 In the last decades, high serum levels of lipoprotein(a) (Lp(a)) have been associated with increased cardiovascular disease (CVD) risk, in particular among individuals with smaller apolipoprotein(a) (apo(a)) isoforms than those with larger sizes. The aim Arrigo F. G. Cicero, Federica Fogacci, Giuseppe Derosa, Angela D’Angelo, Fulvio Ventura, Elisabetta Rizzoli, Sergio D’Addato, Claudio Borghi, on behalf of the Brisighella Heart Study Group +8 moredoaj +1 more sourceMultilevel mobile health approach to improve cardiovascular health in resource-limited communities with Step It Up: a randomised controlled trial protocol targeting physical activity
BMJ Open, 2020 Introduction Although physical activity (PA) reduces cardiovascular disease (CVD) risk, physical inactivity remains a pressing public health concern, especially among African American (AA) women in the USA.Sophie E Claudel, Joniqua N Ceasar, Marcus R Andrews, Valerie M Mitchell, Kosuke Tamura, Gwenyth R Wallen, Nithya P Vijayakumar, James F Troendle, Kaveri Curlin, Sam J Neally, Billy S Collins, Yvonne Baumer, Cristhian A Gutierrez-Huerta, Rafique Islam, Briana S Turner, Kathryn G Tippey, Shayne Giuliano, Regina McCoy, Jessica Zahurak, Sharon Lambert, Philip J Moore, Mary Douglas-Brown, Tonya Dodge, Tiffany M Powell-Wiley +23 moredoaj +1 more sourceCirculating progenitor cell count for cardiovascular risk stratification: a pooled analysis [PDF]
, 2010 Background: Circulating progenitor cells (CPC) contribute to the homeostasis of the vessel wall, and a reduced CPC count predicts cardiovascular morbidity and mortality.Zeiher Andreas M., ZEIHER AM, Saula de Kreutzenberg, Ozaki Takenori, MARUYAMA S, Schmidt-Lucke, Caroline, Andreas M. Zeiher, Takenori Ozaki, Schmidt-Lucke Caroline, Avogaro, Angelo, WERNER N., Meigs, James, Nikos Werner, Meigs James, SCHMIDT LUCKE C, VIGILI DE KREUTZENBERG, SAULA, Shoichi Maruyama, Werner, Nikos, Fadini, Gian Paolo, Nickenig, Georg, OZAKI T, Taguchi Akihiko, DIMMELER S, Caroline Schmidt-Lucke, Werner Nikos, Taguchi, Akihiko, Andreas M Zeiher, MEIGS J, NICKENIG G, Maruyama Shoichi, Angelo Avogaro, Ozaki, Takenori, Gian Paolo Fadini, Fadini Gian Paolo, TAGUCHI A, Dimmeler Stefanie, Stefanie Dimmeler, Dimmeler, Stefanie, De Kreutzenberg, Saula, Maruyama, Shoichi, Akihiko Taguchi, Zeiher, Andreas M., James Meigs, Nickenig Georg, Avogaro Angelo, Georg Nickenig, de Kreutzenberg Saula +46 morecore +2 more sourcesImmune cell phenotyping in low blood volumes for assessment of cardiovascular disease risk, development, and progression: a pilot study
Journal of Translational Medicine, 2020 Background Cardiovascular disease (CVD) is the leading cause of death in the world. Given the role of immune cells in atherosclerosis development and progression, effective methods for characterizing immune cell populations are needed, particularly among Yvonne Baumer, Cristhian A. Gutierrez-Huerta, Ankit Saxena, Pradeep K. Dagur, Steven D. Langerman, Kosuke Tamura, Joniqua N. Ceasar, Marcus R. Andrews, Valerie Mitchell, Billy S. Collins, Quan Yu, Heather L. Teague, Martin P. Playford, Christopher K. E. Bleck, Nehal N. Mehta, J. Philip McCoy, Tiffany M. Powell-Wiley +16 moredoaj +1 more source